We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MACC.U
576
DELISTED
Mission Advancement Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Redeemable Warrant
MACC.U
$2.23M 0.01%
225,000
DRVN icon
577
Driven Brands
DRVN
$2.47B
$2.23M 0.01%
+77,021
New +$2.28M
ITQRU
578
DELISTED
Itiquira Acquisition Corp. Unit
ITQRU
$2.19M 0.01%
220,000
SAVE
579
DELISTED
Spirit Airlines, Inc.
SAVE
$2.15M 0.01%
82,786
GLBLU
580
DELISTED
Cartesian Growth Corporation Unit
GLBLU
$2.14M 0.01%
210,000
VELOU
581
DELISTED
Velocity Acquisition Corp. Units
VELOU
$2.11M 0.01%
210,000
SPKBU
582
DELISTED
Silver Spike Acquisition Corp II Units
SPKBU
$2.09M 0.01%
208,021
U icon
583
Unity
U
$13.9B
$2.08M 0.01%
16,500
BRO icon
584
Brown & Brown
BRO
$25B
$2.07M 0.01%
+37,253
New +$2.08M
VPCC.U
585
DELISTED
VPC Impact Acquisition Holdings III, Inc. Units, each consisting of one share of Class A common stoc
VPCC.U
$2.04M 0.01%
200,000
FWAC
586
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
$2.03M 0.01%
206,711
TGLS icon
587
Tecnoglass
TGLS
$2.09B
$2.02M 0.01%
+93,193
New +$1.96M
WBT
588
DELISTED
Welbilt, Inc.
WBT
$2.01M 0.01%
+86,500
New +$2.03M
GLTA.U
589
DELISTED
Galata Acquisition Corp. Units, each consisting of one class A ordinary share and one-half of one warrant
GLTA.U
$2M 0.01%
+200,000
New +$2M
DNZ.U
590
DELISTED
D and Z Media Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Warrant
DNZ.U
$1.99M 0.01%
200,000
BRIVU
591
DELISTED
B. Riley Principal 250 Merger Corp. Units
BRIVU
$1.98M 0.01%
200,000
RMGCU
592
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
$1.98M 0.01%
200,000
APYX icon
593
Apyx Medical
APYX
$163M
$1.97M 0.01%
142,575
+14,794
+12% +$156K
TSPQ.U
594
DELISTED
TCW Special Purpose Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TSPQ.U
$1.97M 0.01%
200,000
FVIV.U
595
DELISTED
Fortress Value Acquisition Corp. IV Units, each consisting of one share of Class A common stock and one-eighth of one redeemable Warrant
FVIV.U
$1.97M 0.01%
200,000
CLRMU
596
DELISTED
Clarim Acquisition Corp. Unit
CLRMU
$1.97M 0.01%
200,000
VAQC
597
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$1.95M 0.01%
200,000
GXO icon
598
GXO Logistics
GXO
$6.13B
$1.94M 0.01%
+24,727
New +$1.94M
IFF icon
599
International Flavors & Fragrances
IFF
$20.2B
$1.89M 0.01%
14,128
+1,246
+10% +$183K
CPRI icon
600
Capri Holdings
CPRI
$1.88B
$1.85M 0.01%
38,150

Similar funds

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.